0001181431-14-020173.txt : 20140519 0001181431-14-020173.hdr.sgml : 20140519 20140519161208 ACCESSION NUMBER: 0001181431-14-020173 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140515 FILED AS OF DATE: 20140519 DATE AS OF CHANGE: 20140519 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OXIGENE INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CHAPLIN DAVID CENTRAL INDEX KEY: 0001167232 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21990 FILM NUMBER: 14854756 4 1 rrd409733.xml CHAPLIN FORM 4 X0306 4 2014-05-15 0 0000908259 OXIGENE INC OXGN 0001167232 CHAPLIN DAVID C/O OXIGENE, INC. 701 GATEWAY BLVD, SUITE 210 SOUTH SAN FRANCISCO CA 94080 1 1 0 0 President and CEO Employee Stock Option (Right to Buy) 2.95 2014-05-15 4 A 0 150000 0 A 2024-05-15 Common Stock 150000 150000 D Dr. Chaplin was awarded options to purchase shares of OXiGENE, Inc. common stock, $0.01 par value per share (the "Stock Options"), pursuant to the OXiGENE, Inc. 2005 Stock Plan, as amended, as partial payment for services to be provided with respect to his service as President and Chief Executive Officer. The first 25% of the Stock Options will vest on the one year anniversary of the grant date, and the remainder will vest monthly in 36 equal installments starting one month after the one year anniversary of the grant date. /s/ Megan N. Gates, Attorney-in-fact 2014-05-19